Literature DB >> 33445786

Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature.

Valentina Giudice1,2,3, Chiara Cardamone1,4, Massimo Triggiani1,4, Carmine Selleri1,3.   

Abstract

Bone marrow failure (BMF) syndromes are a heterogenous group of non-malignant hematologic diseases characterized by single- or multi-lineage cytopenia(s) with either inherited or acquired pathogenesis. Aberrant T or B cells or innate immune responses are variously involved in the pathophysiology of BMF, and hematological improvement after standard immunosuppressive or anti-complement therapies is the main indirect evidence of the central role of the immune system in BMF development. As part of this immune derangement, pro-inflammatory cytokines play an important role in shaping the immune responses and in sustaining inflammation during marrow failure. In this review, we summarize current knowledge of cytokine signatures in BMF syndromes.

Entities:  

Keywords:  aplastic anemia; bone marrow failure syndromes; cytokines; myelodysplastic syndromes

Mesh:

Substances:

Year:  2021        PMID: 33445786      PMCID: PMC7828244          DOI: 10.3390/ijms22020705

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  146 in total

1.  Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.

Authors:  Luigi J Alvarado; Heather D Huntsman; Hai Cheng; Danielle M Townsley; Thomas Winkler; Xingmin Feng; Cynthia E Dunbar; Neal S Young; Andre Larochelle
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

Review 2.  Myelodysplastic syndromes: the complexity of stem-cell diseases.

Authors:  Seth J Corey; Mark D Minden; Dwayne L Barber; Hagop Kantarjian; Jean C Y Wang; Aaron D Schimmer
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

Review 3.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.

Authors:  Michael J Clemente; Marcin W Wlodarski; Hideki Makishima; Aaron D Viny; Isabell Bretschneider; Mohammad Shaik; Nelli Bejanyan; Alan E Lichtin; Eric D Hsi; Eric D His; Ronald L Paquette; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

5.  Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity.

Authors:  Rajib De; Atreyee Dutta; Tuphan Kanti Dolai; Kakoli Ghosh; Ajanta Halder
Journal:  Hematology       Date:  2018-08-23       Impact factor: 2.269

6.  Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome.

Authors:  Adam W Mailloux; Chiharu Sugimori; Rami S Komrokji; Lili Yang; Jaroslaw P Maciejewski; Mikkael A Sekeres; Ronald Paquette; Thomas P Loughran; Alan F List; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

7.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Identification and treatment of late onset Fanconi's anemia.

Authors:  A Zatterale; R Calzone; S Renda; L Catalano; C Selleri; R Notaro; B Rotoli
Journal:  Haematologica       Date:  1995 Nov-Dec       Impact factor: 9.941

9.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

10.  Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.

Authors:  J P Maciejewski; J R Hibbs; S Anderson; P Katevas; N S Young
Journal:  Exp Hematol       Date:  1994-10       Impact factor: 3.084

View more
  3 in total

Review 1.  Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness.

Authors:  Carlos Bravo-Pérez; Salvador Carrillo-Tornel; Esmeralda García-Torralba; Andrés Jerez
Journal:  Cancers (Basel)       Date:  2022-03-05       Impact factor: 6.639

2.  3D in-vitro cultures of human bone marrow and Wharton's jelly derived mesenchymal stromal cells show high chondrogenic potential.

Authors:  Erwin Pavel Lamparelli; Maria Camilla Ciardulli; Valentina Giudice; Pasqualina Scala; Rosa Vitolo; Tina Patricia Dale; Carmine Selleri; Nicholas Robert Forsyth; Nicola Maffulli; Giovanna Della Porta
Journal:  Front Bioeng Biotechnol       Date:  2022-09-26

Review 3.  Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.

Authors:  Antonio G Solimando; Carmen Palumbo; Mary Victoria Pragnell; Max Bittrich; Antonella Argentiero; Markus Krebs
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.